Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Myriad Genetics (MYGN) over the last 17 years, with Q3 2025 value amounting to $71.0 million.

  • Myriad Genetics' Other Operating Expenses fell 152.57% to $71.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $622.5 million, marking a year-over-year increase of 8228.4%. This contributed to the annual value of $319.6 million for FY2024, which is 2049.75% down from last year.
  • Per Myriad Genetics' latest filing, its Other Operating Expenses stood at $71.0 million for Q3 2025, which was down 152.57% from $388.6 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Other Operating Expenses ranged from a high of $388.6 million in Q2 2025 and a low of $47.8 million during Q3 2021
  • Over the past 5 years, Myriad Genetics' median Other Operating Expenses value was $71.0 million (recorded in 2025), while the average stood at $94.5 million.
  • Per our database at Business Quant, Myriad Genetics' Other Operating Expenses plummeted by 3762.01% in 2024 and then surged by 36042.65% in 2025.
  • Quarter analysis of 5 years shows Myriad Genetics' Other Operating Expenses stood at $107.8 million in 2021, then rose by 15.86% to $124.9 million in 2022, then fell by 7.45% to $115.6 million in 2023, then dropped by 18.94% to $93.7 million in 2024, then fell by 24.23% to $71.0 million in 2025.
  • Its Other Operating Expenses stands at $71.0 million for Q3 2025, versus $388.6 million for Q2 2025 and $69.2 million for Q1 2025.